Loading...
Loading...
NARI| Name | Value |
|---|---|
| Revenues | 153.4M |
| Cost of Revenue | 19.8M |
| Gross Profit | 133.5M |
| Operating Expense | 140.2M |
| Operating I/L | -13.6M |
| Other Income/Expense | 0.9M |
| Interest Income | 1.1M |
| Pretax | -12.7M |
| Income Tax Expense | 5.7M |
| Net Income/Loss | -18.4M |
Inari Medical, Inc. is a medical device company specializing in the development, manufacturing, marketing, and sales of devices for the interventional treatment of venous diseases in the United States. The company's primary products include ClotTriever, a mechanical thrombectomy system for removing large clots from large vessels and treating deep vein thrombosis, as well as FlowTriever, a catheter-based aspiration and mechanical thrombectomy system for pulmonary embolism treatment. Additionally, they offer FlowSaver, FlowStasis, and FlowTriever 2, designed to address various aspects of venous access site and clot removal. Inari Medical generates revenue through the sale of these medical devices.
